Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSBerberrubine is an isoquinoline alkaloid that has been found in C. chinensis and has diverse biological activities.1,2,3,4,5,6,7 It is also an active metabolite of berberine (Item No. 10006427).1,2 Berberrubine (600 µM) scavenges hydroxyl radicals and chelates ferrous iron in cell-free assays.3 It potentiates topoisomerase II-induced cleavage of isolated E. coli DNA when used at a concentration of 10 µM.4 Berberrubine inhibits N-methyl-4-phenylpyridinium (MPP+) uptake in MDCK cells expressing human organic cation transporter 1 (OCT1), OCT2, or OCT3 (IC50s = 1.26, 8.3, and 4.88 µM, respectively).5 It decreases triglyceride levels without inducing cytotoxicity in HepG2 liver cells when used at a concentration of 15 µM.6 In vivo, berberrubine (20 mg/kg per day) increases intestinal length, decreases disease severity and colonic epithelial deterioration, reduces colonic TNF-α, IFN-γ, IL-6, IL-1β, IL-4, and IL-10 levels, and decreases colonic myeloperoxidase (MPO) activity in a mouse model of ulcerative colitis induced by dextran sodium sulfate (DSS).7
WARNING This product is not for human or veterinary use.
1. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes. J. Transl. Med. 9, 62 (2011).
2. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-
3. Hydroxyl radical scavenging activities of isoquinoline alkaloids isolated from Coptis chinensis. Arch. Pharm. Res. 32(3), 341-345 (2009).
4. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes. Planta Med. 61(5), 414-418 (1995).
5. Interaction of six protoberberine alkaloids with human organic cation transporters 1, 2 and 3. Xenobiotica 46(2), 175-183 (2016).
6. Berberine metabolites exhibit triglyceride-
7. Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-